Back to search

Article

Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA Vaccination in Generating Protective Mucosal and Systemic Immunity Against Influenza A (H1N1)

2024-09-01

Abstract excerpt

Four significant influenza outbreaks have occurred over the past 100 years, and the 1918 flu pandemic is the most severe. Since influenza viruses undergo antigenic evolution, they are the pathogens most likely to trigger a new pandemic shortly. Intranasal vaccination offers a promising strategy for preventing diseases triggered by respiratory viruses by eliciting an immunoglobulin A (IgA) response, limiting virus...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9760cea1-19b8-56a5-ad26-18ca70c63302
DOI
10.22541/au.172523004.48662440/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA Vaccination in Generating Protective Mucosal and Systemic Immunity Against Influenza A (H1N1)DOI 10.22541/au.172523004.48662440/v1
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza VirusesSemantic proximity
Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequenceSemantic proximity
An mRNA vaccine candidate encoding H5HA clade 2.3.4.4b protects mice from clade 2.3.2.1a virus infectionSemantic proximity
Advances in Nanoparticle-Enhanced Vaccine Strategies: Towards a Universal Protection Against Influenza B VirusesSemantic proximity
An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A virusesSemantic proximity
Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques.Semantic proximity
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodiesSemantic proximity
Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virusSemantic proximity
Challenges and opportunities in the development of mucosal mRNA vaccinesSemantic proximity
Effect of Acid-Stabilizing Hemagglutinin Mutations on Immunogenicity and Heterologous Protection by H1N1 Influenza Virus mRNA-LNP Vaccines.Semantic proximity
Intranasal Immunization with Recombinant Hemagglutinin of Influenza A/H5 Virus Complexed with Novochizol Induces Virus-Neutralizing Antibodies and Protects Animals from Lethal Viral ChallengeSemantic proximity
Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 responsesSemantic proximity
Select a neighboring publication to make it the new centre.